Archimedes

Archimedes Senior Management Team

A wide spectrum of knowledge, experience and know-how.

Archimedes’ entrepreneurial management team has a proven track record in building and growing profitable European specialty pharmaceutical businesses and has extensive operational, marketing and financial experience across the international pharmaceutical industry.

Richard de Souza.
Chief Executive.
Richard previouslyserved for four years as Director, International at Shire Pharmaceuticals where he was responsible for significant growth of the Pharma Business in Europe and Asia Pacific and the Diagnostics and Biologicals globally. Prior to this, Richard was at Warner Lambert, which he joined in 1999 as President Europe and International, leaving after the merger with Pfizer. Richard is a pharmacist who started his career at Smith Kline Beecham in Manufacturing before moving through Business Development and Marketing roles into General Management and in 1995 he was appointed Chairman, Europe Pharma.

Tim Watts.
Chief Financial Officer.
Tim is a Chartered Accountant who started his career at Coopers and Lybrand and H J Heinz. He has 17 years experience in the pharmaceutical industry at AstraZeneca. Between 2001 and 2006, Tim was AstraZeneca’s Group Financial Controller during which time he oversaw the transition to IFRS and the compliance requirements of Sarbanes-Oxley. Whilst at AZ Tim also held finance roles in Sales & Marketing, R & D and in the Supply Chain as well as an operating role as Regional Director for the Nordic markets.

Charles Marchetti.
Group Services and Operations Director.
Charles is a Chartered Accountant who started his career at PWC followed by several Europe wide Finance Director roles in consumer products before moving into Healthcare with SmithKline Beecham, Scholl Plc and Shire. Within his remit in these roles, he has had Supply Chain, IT, Legal and HR responsibilities. In addition he has also been Regional Director for businesses in Asia/Pacific, Latin America and Southern Europe as well as holding Managing Director roles in Italy and Greece.

Michael Clark.
Group Marketing and Business Development Director.
Michael established the first marketing team at Shire Pharmaceuticals having joined the company as a start up in 1992. By 2000, Shire had become the UK’s number one specialty pharmaceutical business by turnover. In 2001 Michael moved into the International group as Marketing Director, International where he was responsible for successfully implementing Shire’s first European marketing and business development strategies. Michael’s additional responsibilities saw him lead the team providing input into Shire’s R & D group on behalf of the European and Asia Pacific operations. Michael is a pharmacologist who started his career in research before moving into sales and marketing roles with Wyeth UK.

Alan Smith, Ph.D.
Vice President, Research & Development.
Alan Smith is a pharmacist who started his industrial career in research at Glaxo before moving into R&D at Boots Pharmaceuticals in 1979 where he was responsible for all aspects of development in bringing candidate drugs into clinical trials. He joined West Pharmaceutical Services in 1998 to take charge of Development in the UK, becoming Vice President of Research & Development in 2002, joining Archimedes in the same role following their acquisition of West’s pharmaceutical drug delivery business.